Literature DB >> 28927290

Biomarkers and their impact on precision medicine.

William Slikker1.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28927290      PMCID： PMC5813864          DOI： 10.1177/1535370217733426

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN： 1535-3699


× No keyword cloud information.
  6 in total

Review 1.  Biomarkers and surrogate endpoints: preferred definitions and conceptual framework.

Authors: 
Journal:  Clin Pharmacol Ther       Date:  2001-03       Impact factor: 6.875

2.  A brief history of the clinical thermometer.

Authors:  J M S Pearce
Journal:  QJM       Date:  2002-04

3.  Bring on the biomarkers.

Authors:  George Poste
Journal:  Nature       Date:  2011-01-13       Impact factor: 49.962

4.  Point: The Imprecise Pursuit of Precision Medicine: Are Biomarkers to Blame?

Authors:  Bishal Gyawali
Journal:  J Natl Compr Canc Netw       Date:  2017-07       Impact factor: 11.908

5.  Qualifying biomarkers for use in drug development: a US Food and Drug Administration overview.

Authors:  Janet Woodcock; Shaavhree Buckman; Federico Goodsaid; Marc K Walton; Issam Zineh
Journal:  Expert Opin Med Diagn       Date:  2011-09

6.  Counterpoint: Successes in the Pursuit of Precision Medicine: Biomarkers Take Credit.

Authors:  Shumei Kato; Vivek Subbiah; Razelle Kurzrock
Journal:  J Natl Compr Canc Netw       Date:  2017-07       Impact factor: 11.908
  6 in total
  3 in total

1.  Rapid Quantum Magnetic IL-6 Point-of-Care Assay in Patients Hospitalized with COVID-19.

Authors:  Johnny Atallah; Dakota Archambault; Jeffrey D Randall; Adam Shepro; Lauren E Styskal; David R Glenn; Colin B Connolly; Katelin Katsis; Kathleen Gallagher; Musie Ghebremichael; Michael K Mansour
Journal:  Diagnostics (Basel)       Date:  2022-05-07

Review 2.  L-Carnitine and Acylcarnitines: Mitochondrial Biomarkers for Precision Medicine.

Authors:  Marc R McCann; Mery Vet George De la Rosa; Gus R Rosania; Kathleen A Stringer
Journal:  Metabolites       Date:  2021-01-14

3.  Increased plasma brain-derived neurotrophic factor (BDNF) as a potential biomarker for and compensatory mechanism in mild cognitive impairment: a case-control study.

Authors:  Ted Kheng Siang Ng; Christina Coughlan; Patricia C Heyn; Alex Tagawa; James J Carollo; Ee Heok Kua; Rathi Mahendran
Journal:  Aging (Albany NY)       Date:  2021-10-15       Impact factor: 5.682
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.